A detailed history of Invesco Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Invesco Ltd. holds 3,617,113 shares of AMGN stock, worth $1.04 Billion. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,617,113
Previous 3,273,762 10.49%
Holding current value
$1.04 Billion
Previous $1.02 Billion 13.94%
% of portfolio
0.23%
Previous 0.22%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $106 Million - $116 Million
343,351 Added 10.49%
3,617,113 $1.17 Billion
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $46.6 Million - $56.6 Million
177,255 Added 5.72%
3,273,762 $1.02 Billion
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $104 Million - $126 Million
-388,335 Reduced 11.14%
3,096,507 $880 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $32.9 Million - $37.1 Million
128,483 Added 3.83%
3,484,842 $1 Billion
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $100 Million - $125 Million
459,340 Added 15.86%
3,356,359 $902 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $58.6 Million - $69.3 Million
-273,593 Reduced 8.63%
2,897,019 $643 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $88.3 Million - $108 Million
390,917 Added 14.06%
3,170,612 $766 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $35.7 Million - $45.4 Million
156,028 Added 5.95%
2,779,695 $730 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $22.2 Million - $25.1 Million
-99,099 Reduced 3.64%
2,623,667 $591 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $15.7 Million - $17.5 Million
-67,978 Reduced 2.44%
2,722,766 $662 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $75.6 Million - $83.7 Million
344,875 Added 14.1%
2,790,744 $675 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $106 Million - $121 Million
533,328 Added 27.89%
2,445,869 $550 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $40.9 Million - $47.9 Million
192,511 Added 11.19%
1,912,541 $407 Million
Q2 2021

Aug 17, 2021

SELL
$233.58 - $259.14 $107 Million - $118 Million
-456,406 Reduced 20.97%
1,720,030 $419 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $1.37 Million - $1.59 Million
6,160 Added 0.28%
2,176,436 $542 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $219 Million - $261 Million
-1,011,596 Reduced 31.79%
2,170,276 $499 Million
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $202 Million - $225 Million
861,772 Added 37.14%
3,181,872 $809 Million
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $103 Million - $126 Million
519,744 Added 28.87%
2,320,100 $547 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $27.9 Million - $37 Million
153,003 Added 9.29%
1,800,356 $365 Million
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $1.04 Billion - $1.34 Billion
-5,513,983 Reduced 77.0%
1,647,353 $397 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $61.2 Million - $73.3 Million
-351,289 Reduced 4.68%
7,161,336 $1.39 Billion
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $57.9 Million - $67.8 Million
-347,101 Reduced 4.42%
7,512,625 $1.38 Billion
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $44.2 Million - $49.8 Million
244,502 Added 3.21%
7,859,726 $1.49 Billion
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $1.36 Billion - $1.59 Billion
7,615,224 New
7,615,224 $1.48 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.